Related Experiment Video
Updated: Jun 15, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Morgana/chp-1, a ROCK inhibitor involved in centrosome duplication and tumorigenesis
Roberta Ferretti1, Valeria Palumbo, Augusta Di Savino
1Dipartimento di Genetica, Biologia e Biochimica, Università di Torino, 10126 Torino, Italy.
Abstract:
Centrosome abnormalities lead to genomic instability and are a common feature of many cancer cells. Here we show that mutations in morgana/chp-1 result in centrosome amplification and lethality in both Drosophila and mouse, and that the fly centrosome phenotype is fully rescued by the human ortholog of morgana. In mouse cells, morgana forms a complex with Hsp90 and ROCK I and II, and directly binds ROCK II. Morgana downregulation promotes the interaction between ROCK II and nucleophosmin (NPM), leading to an increased ROCK II kinase activity, which results in centrosome amplification. Morgana(+/-) primary cells and mice display an increased susceptibility to neoplastic transformation. In addition, tumor tissue array histochemical analysis revealed that morgana is underexpressed in a large fraction of breast and lung human cancers. Thus, morgana/chp-1 appears to prevent both centrosome amplification and tumorigenesis.
Insights
Mutations in morgana/chp-1 cause centrosome amplification and lethality. Morgana/chp-1 acts as a tumor suppressor by preventing centrosome amplification and neoplastic transformation.
Area of Science:
- Cell Biology
- Cancer Research
- Genetics
Background:
- Centrosome abnormalities are linked to genomic instability and are prevalent in cancer cells.
- The role of morgana/chp-1 in centrosome regulation and tumorigenesis is not fully understood.
Purpose of the Study:
- To investigate the function of morgana/chp-1 in centrosome duplication and its implications in cancer.
- To elucidate the molecular mechanism by which morgana/chp-1 regulates centrosome amplification.
Main Methods:
- Utilized Drosophila and mouse models to study the effects of morgana/chp-1 mutations.
- Investigated protein interactions in mouse cells, including morgana, Hsp90, ROCK I/II, and NPM.
- Analyzed neoplastic transformation susceptibility in morgana(+/-) cells and mice.
- Performed tumor tissue array histochemical analysis on human breast and lung cancer samples.
Main Results:
- Mutations in morgana/chp-1 led to centrosome amplification and lethality in both Drosophila and mouse.
- The human ortholog of morgana rescued the fly centrosome phenotype.
- Morgana downregulation in mouse cells increased ROCK II kinase activity via enhanced ROCK II-NPM interaction, causing centrosome amplification.
- Morgana(+/-) cells and mice showed increased susceptibility to neoplastic transformation.
- Morgana was found to be underexpressed in human breast and lung cancers.
Conclusions:
- Morgana/chp-1 plays a critical role in preventing centrosome amplification.
- Morgana/chp-1 functions as a tumor suppressor by inhibiting centrosome amplification and neoplastic transformation.
- Dysregulation of morgana/chp-1 is implicated in human cancers.
Related Concept Videos
Centrosome Duplication
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...
Centrosome Duplication
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...
Anaphase Promoting Complex
Anaphase Promoting Complex
Abnormal Proliferation
Negative Regulator Molecules

